跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
劉 彥麟
副教授
,
小兒學科
主治醫師
,
臺北醫學大學附設醫院
成員
,
臺北醫學大學癌症轉譯研究中心
成員
,
臺北醫學大學神經醫學研究中心
https://orcid.org/0000-0002-7571-3123
電子郵件
ylliu
tmu.edu
tw
No. 250 Wu-Xing Street, Taipei 11031
No. 250 Wu-Xing Street, Taipei 11031
h-index
716
引文
15
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2012
2025
每年研究成果
概覽
指紋
網路
專案
(8)
研究成果
(73)
資料集
(2)
類似的個人檔案
(6)
指紋
查看啟用 Yen-Lin Liu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Ganglioneuroblastoma
100%
Neoplasm
66%
Childhood Cancer
60%
Pediatrics
58%
Fluorine-18
39%
Haemophilia A
33%
Acute Lymphoblastic Leukemia
31%
Brain Tumor
29%
Malignant Neoplasm
28%
Medulloblastoma
28%
DOPA
28%
Leukemia
24%
Disease
23%
Risk Stratification
22%
Fluorodeoxyglucose F 18
21%
Patient with Hemophilia
21%
Haemophilia
21%
Neuroblastoma Cell
19%
Patient with Neuroblastoma
19%
Circulating Tumor Cell
19%
Health Care Cost
19%
Infection
19%
Atypical Teratoid Rhabdoid Tumor
19%
Stem Cell
19%
Minimal Residual Disease
19%
Positron Emission Tomography-Computed Tomography
19%
Ganglioglioma
19%
Metastatic Carcinoma
16%
Radiation Therapy
16%
Pediatric Cancer
16%
In Vitro
15%
Bleeding
15%
Oncogene
14%
Epileptic Seizure
14%
Pediatrics Patient
14%
Overall Survival
13%
Central Nervous System
13%
Pediatric Brain Tumor
13%
Positron Emission Tomography
12%
Drug Sensitivity
12%
Clinical Feature
11%
Diagnosis
11%
Ex Vivo
11%
Hemarthrosis
11%
Solid Malignant Neoplasm
11%
Toddlers
11%
Hemophilic Arthropathy
10%
Drug Screening
10%
Functional Status
10%
Drug Resistance
10%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
53%
Neoplasm
50%
Haemophilia
28%
Bleeding
24%
Haemophilia A
24%
Brain Tumor
23%
Childhood Cancer
23%
Neuroblastoma
20%
Disease
16%
Hemarthrosis
15%
Von Willebrand Factor
15%
Antitumor Activity
10%
Trough Level
10%
Drug Screening
10%
Drug Resistance
10%
Optical Imaging
9%
Blood Clotting Factor 8
9%
Leukemia
9%
Solid Malignant Neoplasm
9%
Preclinical Study
9%
STAT3 Protein
9%
Small Cell Lung Cancer
9%
Pharmacokinetics
9%
Cohort Study
9%
Iron Deficiency
9%
Developmental Delay
9%
Ibrutinib
9%
Medulloblastoma
9%
Anemia
9%
Clinical Feature
9%
Arthralgia
8%
Green Fluorescent Protein
7%
Chimeric Protein
6%
Glioma
6%
Temozolomide
6%
Adverse Event
5%
Glioblastoma
5%
Iron Deficiency Anemia
5%
Symptom
5%
Infection
5%
Nursing and Health Professions
Malignant Neoplasm
21%
Haemophilia A
20%
Childhood Cancer
19%
Haemophilia
19%
Cancer Therapy
19%
Brain Tumor
19%
Prevalence
15%
Muscle Thickness
13%
Neuroblastoma
11%
Functional Status
10%
Cross-Sectional Study
10%
Leukemia
10%
Hemophilic Arthropathy
10%
Health Status
10%
Mental Health
9%
National Health Insurance
9%
Cancer Diagnosis
9%
Cohort Analysis
9%
Health Care Utilization
9%
International Classification of Functioning, Disability and Health
9%
Solid Malignant Neoplasm
9%
Walking Distance
9%
Half Life Time
9%
Muscle Mass
9%
Oncology Nurse
9%
Cancer Screening
9%
Social Media
9%
Depressive Disorder
9%
Walk Test
9%
Disease
8%
Odds Ratio
7%
Health Service
6%
Distress Syndrome
6%
Care Group
6%
Symptom
6%
Outpatient
5%
Teaching Hospital
5%
